MANCHESTER, England--()--Gentronix Limited, the genotoxicity innovation and service company, is pleased to announce that it has received French research tax credit approval for years 2012 through 2014.
“We are extremely pleased to receive this approval from the French Ministry of Research since it will provide Gentronix with greater opportunities to support current and future customers in this important European market.”
The French Ministry of Research (Ministère de l'Enseignement Supérieur et de la Recherche) has granted the French R&D tax credit ("Crédit d'Impôt Recherche", CIR) accreditation to Gentronix as of October 2012. This initiative allows eligible research-intensive French companies who are subject to corporate tax in France, the ability to claim tax relief on costs generated in R&D requirements that are outsourced to Gentronix.
John Nicholson, CEO and Chairman of Gentronix commented: “We are extremely pleased to receive this approval from the French Ministry of Research since it will provide Gentronix with greater opportunities to support current and future customers in this important European market.”
Genotoxins are chemicals that can damage DNA, and may be carcinogens. Gentronix Ltd provides genotoxicity screening products and services for companies who develop new compounds in fields such as pharmaceuticals, agrichemicals, flavours and fragrances, personal care and consumer products.
In addition to conventional genotoxicity testing, Gentronix uses its own patented assays, BlueScreen™HC and GreenScreen®HC, which use human cells that have been genetically modified to give a sensitive and specific response when a chemical damages or interferes with its DNA. For more information, see http://www.gentronix.co.uk/, or email us at email@example.com.